Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen
Status:
Active, not recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to test non-inferiority of aflibercept "treat and
extend" using a relaxed retinal fluid management relative to aflibercept "treat and extend"
using a strict retinal fluid management SD-OCT (spectral domain optical coherence tomography)
disease activity guided retreatment with respect to best-corrected visual acuity (BCVA) from
baseline to end of treatment.